Proteomics International Laboratories Ltd (ASX:PIQ) Investor presentation - Bell Potter Healthcare Conference

Perth, Nov 18, 2025 AEST (ABN Newswire) - Proteomics International Laboratories Ltd (ASX:PIQ) (PIQLF:OTCMKTS) released a copy of the presentation to be provided by Dr Richard Lipscombe to attendees of the Bell Potter Healthcare Conference, a virtual event being held 18-20 November 2025.

Proteomics International will present on Thursday, 20 November at 1pm (AEDT).

*To view the presentation slides, please visit:
https://abnnewswire.net/lnk/12E033TE


About Proteomics International Laboratories Ltd

Proteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.

 

Contact

Dr Richard Lipscombe Managing Director Proteomics International Laboratories Ltd T: +61 8 9389 1992 E: enquiries@proteomicsinternational.com Dirk van Dissel Investor Relations and Corporate Advisor Candour Advisory T: +61 408 326 367 E: dirk@candouradvisory.com.au Matthew Wright Media and Public Relations NWR Communications T: +61 451 896 420 E: matt@nwrcommunications.com.au Proteomics International (Europe) Plesmanweg 9, 7602 PD Almelo The Netherlands T: +31 85 40 11 173 E: Europe@PromarkerD.eu